| Serial Number | 90819289 |
| Word Mark | VALENCIA |
| Filing Date | Friday, July 9, 2021 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, December 26, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 29, 2022 |
| Goods and Services | Providing medical and scientific research information in the field of pharmaceuticals and clinical trials |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 16, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | AbbVie Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | North Chicago, IL 60064 |
| Party Name | AbbVie Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | North Chicago, IL 60064 |
| Event Date | Event Description |
| Tuesday, December 27, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, December 26, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, May 24, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, March 29, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 29, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 9, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, February 23, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, February 22, 2022 | ASSIGNED TO EXAMINER |
| Thursday, September 16, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Tuesday, July 13, 2021 | NEW APPLICATION ENTERED IN TRAM |